201 related articles for article (PubMed ID: 1157014)
21. Spontaneous regression of metastatic malignant melanoma.
Mikhail GR; Gorsulowsky DC
J Dermatol Surg Oncol; 1986 May; 12(5):497-500. PubMed ID: 3700829
[TBL] [Abstract][Full Text] [Related]
22. Completely regressed primary cutaneous malignant melanoma with nodal and/or visceral metastases: a report of 5 cases and assessment of the literature and diagnostic criteria.
High WA; Stewart D; Wilbers CR; Cockerell CJ; Hoang MP; Fitzpatrick JE
J Am Acad Dermatol; 2005 Jul; 53(1):89-100. PubMed ID: 15965428
[TBL] [Abstract][Full Text] [Related]
23. [Anatomo-clinical criteria of cutaneous melanoma with spontaneous and complete regression. Apropos of a case].
Saint-Blancard P; Nottet JB; Lanternier G; Le Guyadec T; Gouteyron JF; Le Vagueresse R
Arch Anat Cytol Pathol; 1997; 45(4):234-7. PubMed ID: 9406484
[TBL] [Abstract][Full Text] [Related]
24. Spontaneous regression of malignant melanoma: a review of the literature on incidence, clinical features, and possible mechanisms.
Nathanson
Natl Cancer Inst Monogr; 1976 Nov; 44():67-76. PubMed ID: 799762
[TBL] [Abstract][Full Text] [Related]
25. [Preliminary results of immuno-surgical treatment of primary melanoma (author's transl)].
Vanwicjk R; Rustin P; Malek-Mansour S; Castermans-Elias S; Castermans A
Acta Chir Belg; 1975 Jul; 74(4):430-40. PubMed ID: 1146463
[TBL] [Abstract][Full Text] [Related]
26. Active specific and active non-specific immunotherapy in patients with malignant melanoma.
Kokoschka EM; Cerni C; Micksche M
Oncology; 1977; 34(5):229-33. PubMed ID: 917456
[TBL] [Abstract][Full Text] [Related]
27. [Decrease in immunoreactivity in melanoma. Analysis of DNCB tests in the literature].
Remy W; Dorn R; Ulm K; Mayerhausen W
Z Hautkr; 1986 Dec; 61(24):1767-77. PubMed ID: 3825218
[TBL] [Abstract][Full Text] [Related]
28. Immunologic aspects of unknown primary melanoma.
Giuliano AE; Moseley HS; Irie RF; Golub SH; Morton DL
Surgery; 1980 Jan; 87(1):101-5. PubMed ID: 7350713
[TBL] [Abstract][Full Text] [Related]
29. Sequential immune escape and shifting of T cell responses in a long-term survivor of melanoma.
Yamshchikov GV; Mullins DW; Chang CC; Ogino T; Thompson L; Presley J; Galavotti H; Aquila W; Deacon D; Ross W; Patterson JW; Engelhard VH; Ferrone S; Slingluff CL
J Immunol; 2005 Jun; 174(11):6863-71. PubMed ID: 15905528
[TBL] [Abstract][Full Text] [Related]
30. Metastatic malignant melanoma with spontaneous and complete regression of the primary lesion. Case report and review of the literature.
Shai A; Avinoach I; Sagi A
J Dermatol Surg Oncol; 1994 May; 20(5):342-5. PubMed ID: 8176047
[TBL] [Abstract][Full Text] [Related]
31. Spontaneous regression of multiple melanocytic nevi after melanoma: report of 3 cases.
Martín JM; Pinazo I; Monteagudo C; Markovic J; Allende A; Jordá E
Am J Dermatopathol; 2014 Nov; 36(11):e183-8. PubMed ID: 25343215
[TBL] [Abstract][Full Text] [Related]
32. A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III).
Balch CM; Soong SJ; Murad TM; Smith JW; Maddox WA; Durant JR
J Clin Oncol; 1983 Feb; 1(2):126-34. PubMed ID: 6668496
[TBL] [Abstract][Full Text] [Related]
33. Spontaneous partial regression of malignant melanoma and its first metastasis. Case report.
Faxén A; Kock NG; Boeryd B
Scand J Plast Reconstr Surg; 1976; 10(3):245-6. PubMed ID: 1053454
[TBL] [Abstract][Full Text] [Related]
34. Regional lymphatic immunity in melanoma.
Grotz TE; Mansfield AS; Jakub JW; Markovic SN
Melanoma Res; 2012 Feb; 22(1):9-18. PubMed ID: 22082957
[TBL] [Abstract][Full Text] [Related]
35. Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.
Mortarini R; Piris A; Maurichi A; Molla A; Bersani I; Bono A; Bartoli C; Santinami M; Lombardo C; Ravagnani F; Cascinelli N; Parmiani G; Anichini A
Cancer Res; 2003 May; 63(10):2535-45. PubMed ID: 12750277
[TBL] [Abstract][Full Text] [Related]
36. Analysis of soluble melanoma cell membrane antigens in metastatic cells of various organs and further studies of antigens present in primary melanoma.
Hollinshead AC
Cancer; 1975 Oct; 36(4):1282-8. PubMed ID: 51680
[TBL] [Abstract][Full Text] [Related]
37. Complete regression of primary malignant melanoma.
Emanuel PO; Mannion M; Phelps RG
Am J Dermatopathol; 2008 Apr; 30(2):178-81. PubMed ID: 18360126
[TBL] [Abstract][Full Text] [Related]
38. Regression of primary melanoma with metastases.
Avril MF; Charpentier P; Margulis A; Guillaume JC
Cancer; 1992 Mar; 69(6):1377-81. PubMed ID: 1540876
[TBL] [Abstract][Full Text] [Related]
39. Spontaneous regression of metastatic malignant melanoma of the parotid gland and neck lymph nodes: a case report and a review of the literature.
King M; Spooner D; Rowlands DC
Clin Oncol (R Coll Radiol); 2001; 13(6):466-9. PubMed ID: 11824888
[TBL] [Abstract][Full Text] [Related]
40. Spontaneous regression of malignant melanoma - is it based on the interplay between host immune system and melanoma antigens?
Cervinkova M; Kucerova P; Cizkova J
Anticancer Drugs; 2017 Sep; 28(8):819-830. PubMed ID: 28609309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
